M-12

N/A

Report date: 2022/01/10 18:08:25
NME

Base Information

Drug NameM-12
Drug Alias NameM-12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNADPH Oxidase 2 inhibitorsTransient receptor potential cation channel subfamily V member 4 inhibitors
TargetsTransient receptor potential cation channel subfamily V member 4NADPH Oxidase 2
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesJiangnan University
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A